PMC:7253235 / 948-1214 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"33","span":{"begin":5,"end":13},"obj":"Species"},{"id":"38","span":{"begin":37,"end":43},"obj":"Disease"},{"id":"39","span":{"begin":218,"end":224},"obj":"Disease"},{"id":"40","span":{"begin":242,"end":248},"obj":"Disease"}],"attributes":[{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"Tax:9606"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"MESH:D009369"},{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"MESH:D009369"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ncer patients undergoing recent anti-cancer treatment may be at greater risk for sustaining worse outcomes, although data remains suboptimal in this population. Major gaps remain regarding risk associated with type of cancer and type of anti-cancer treatment, as wel"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T9","span":{"begin":37,"end":43},"obj":"Disease"},{"id":"T10","span":{"begin":218,"end":224},"obj":"Disease"},{"id":"T11","span":{"begin":242,"end":248},"obj":"Disease"}],"attributes":[{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"ncer patients undergoing recent anti-cancer treatment may be at greater risk for sustaining worse outcomes, although data remains suboptimal in this population. Major gaps remain regarding risk associated with type of cancer and type of anti-cancer treatment, as wel"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T5","span":{"begin":37,"end":43},"obj":"Phenotype"},{"id":"T6","span":{"begin":218,"end":224},"obj":"Phenotype"},{"id":"T7","span":{"begin":242,"end":248},"obj":"Phenotype"}],"attributes":[{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"ncer patients undergoing recent anti-cancer treatment may be at greater risk for sustaining worse outcomes, although data remains suboptimal in this population. Major gaps remain regarding risk associated with type of cancer and type of anti-cancer treatment, as wel"}